retatrutide ly3437943 glp-1 gip glucagon triple agonist mechanism Beyond GLP -1: Retatrutide's triple-agonist (GLP-1, GIP, glucagon) is redefining metabolic health. Phase 2 data shows ~24% weight loss—surpassing semaglutide & tirzepatide. Evidence-based Medscape | The investigational triple
Pay in 4 interest-free payments of $6.61 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 9 - Oct 14




























![Lapras (8/92) (Stamped) [EX: Legend Maker] 30th Anniversary Promos](https://cdn.shopify.com/s/files/1/0794/9162/9342/files/86617_f94c4228-fca1-4967-9a3c-3d73dc92c515.jpg?v=1776222896)